Evidence map›Paper›PMID 33616658›Full record

ArticleMolecular biology and evolution2021

Adaptive Admixture of HLA Class I Allotypes Enhanced Genetically Determined Strength of Natural Killer Cells in East Asians.

Zhihui Deng, Jianxin Zhen, Genelle F Harrison, Guobin Zhang, Rui Chen, Ge Sun, Qiong Yu, Neda Nemat-Gorgani, Lisbeth A Guethlein, Liumei He and 11 more

Open access · goldAbstract read
In one paragraph

Article in Molecular biology and evolution, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in genetics · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Panobinostat enhances NK cell cytotoxicity in soft tissue sarcoma.Clinical and experimental immunology · 2022
    Article
  17. Article
  18. Human herpesvirus diversity is altered in HLA class I binding peptides.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  19. COVID-19 Pandemic: Escape of Pathogenic Variants and MHC Evolution.International journal of molecular sciences · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 2 countries.

Zhihui DengImmunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
Jianxin ZhenImmunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
Genelle F HarrisonDivision of Biomedical Informatics and Personalized Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Guobin ZhangImmunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
Rui ChenImmunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
Ge SunImmunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
Qiong YuImmunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
Neda Nemat-GorganiDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
Lisbeth A GuethleinDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
Liumei HeImmunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
Mingzhong TangClinical Laboratory, Wuzhou Red Cross Hospital, Wuzhou, Guangxi, P. R. China.
Xiaojiang GaoInflammatory Cell Dynamics Section, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Siqi CaiImmunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
William H PalmerDivision of Biomedical Informatics and Personalized Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Jonathan A ShorttDivision of Biomedical Informatics and Personalized Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Christopher R GignouxDivision of Biomedical Informatics and Personalized Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Mary CarringtonBasic Science Program, Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD21702, and Ragon Institute of MGH, Cambridge, MA, USA.
Hongyan ZouImmunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
Peter ParhamDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
Wenxu HongShenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
Paul J NormanDivision of Biomedical Informatics and Personalized Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0001-8370-7703
Shenzhen Blood Center · CNUniversity of Colorado Anschutz Medical Campus · USStanford University · USNational Cancer Institute · USRagon Institute of MGH, MIT and Harvard · USShenzhen Children's Hospital · CNWuzhou Red Cross Hospital · CN

Funding

Molecular genetics and population studies of the KIR and HLA gene complexesZIABC010792 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CARRINGTON, MARY N. · 2009 to 2025
$7.8M
STRUCTURAL BIOLOGY OF HLA-A,B ANTIGENSR01AI017892 · NIAID · STANFORD UNIVERSITY · PI PARHAM, PETER R · 1985 to 2019
$6.1M
Evolution and Function of Immunogenetic Diversity across the Eastern HemisphereR01AI151549 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Paul John Norman · 2022 to 2026
$3.9M
Evolution and Function of Immunogenetic Diversity Across the Eastern HemisphereR56AI151549 · NIAID · UNIVERSITY OF COLORADO DENVER · PI NORMAN, PAUL JOHN · 2020 to 2020
$387k
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENIAID NIH HHS R01 AI017892NIAID NIH HHS R01 AI151549NIAID NIH HHS R56 AI151549
6 · The paper itself

Abstract

Human natural killer (NK) cells are essential for controlling infection, cancer, and fetal development. NK cell functions are modulated by interactions between polymorphic inhibitory killer cell immunoglobulin-like receptors (KIR) and polymorphic HLA-A, -B, and -C ligands expressed on tissue cells. All HLA-C alleles encode a KIR ligand and contribute to reproduction and immunity. In contrast, only some HLA-A and -B alleles encode KIR ligands and they focus on immunity. By high-resolution analysis of KIR and HLA-A, -B, and -C genes, we show that the Chinese Southern Han (CHS) are significantly enriched for interactions between inhibitory KIR and HLA-A and -B. This enrichment has had substantial input through population admixture with neighboring populations, who contributed HLA class I haplotypes expressing the KIR ligands B*46:01 and B*58:01, which subsequently rose to high frequency by natural selection. Consequently, over 80% of Southern Han HLA haplotypes encode more than one KIR ligand. Complementing the high number of KIR ligands, the CHS KIR locus combines a high frequency of genes expressing potent inhibitory KIR, with a low frequency of those expressing activating KIR. The Southern Han centromeric KIR region encodes strong, conserved, inhibitory HLA-C-specific receptors, and the telomeric region provides a high number and diversity of inhibitory HLA-A and -B-specific receptors. In all these characteristics, the CHS represent other East Asians, whose NK cell repertoires are thus enhanced in quantity, diversity, and effector strength, likely augmenting resistance to endemic viral infections.

Indexed as

Evolution, MolecularGenes, MHC Class IChinaHLA-A AntigensHLA-B AntigensHumansKiller Cells, NaturalReceptors, KIRHLA-A AntigensHLA-B AntigensReceptors, KIRadaptive introgressionadmixtureEast AsiaHLA class Iinfectious diseaseKIRnatural killer cells

Identifiers

PMID33616658
PMCPMC8136484
OpenAlexW3130522262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.